Drugs / Humalog Kwikpen
Regulatory milestones approvals, filings & regulatory actions · 6 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (5) | US (FDA) | HUMALOG KWIKPEN | — | 2000-04-04 – 2012-10-14 | fda.gov ↗ |
| Approved | US (FDA) | HUMALOG KWIKPEN | — | 1996-06-14 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03328845 | Jan 2017 → Nov 2020 | type 1 diabetes mellitus | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Humalog Kwikpen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03328845 ↗ |